Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw

Journal of Nuclear Medicine

Volumn 50, Issue 1, 2009, Pages 30-35

  Dore, Franca ^a,c   Filippi, Luca ^a   Biasotto, Matteo ^b   Chiandussi, Silvia ^b   Cavalli, Fabio ^a   Di Lenarda, Roberto ^b  

^a Maggiore Hospital   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c Universitaria Trieste   (Italy)

Author keywords

Bone scintigraphy; Jaw; Osteonecrosis; SPECT CT

Indexed keywords

GADOLINIUM; MEDRONATE TECHNETIUM TC 99M; OSTEOSOL; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; JAW OSTEONECROSIS; MALE; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANORAMIC RADIOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY COMPUTER ASSISTED TOMOGRAPHY; WHOLE BODY SCINTISCANNING;

AGED; AGED, 80 AND OVER; DIPHOSPHONATES; FEMALE; HUMANS; JAW; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEONECROSIS; RADIOGRAPHY, PANORAMIC; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58249103879     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.048785     Document Type: Article

References (18)

1. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005;63:1567-1575.
2. Bagan JV, Murillo J, Jimenez Y, et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med. 2005;34:120-123.
3. Carter G, Goss AN, Doecke C. Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust. 2005;182:413-415.
4. Woo SB, Hellstein JW, Kalmar JR. Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753-761.
5. Ruggiero S, Gralow J, Marx RE, et al. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract. 2006;2:7-14.
6. Savelli G, Maffioli L, Maccauro M, De Deckere E, Bombardieri E. Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions. Q J Nucl Med. 2001;45:27-37.
7. Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med. 2003;33:205-218.
8. Marx RE, Stern D. Oral and Maxillo-Facial Pathology: A Rationale for Diagnosis and Treatment. Carol Stream, IL: Quintessence; 2003:36-8.
9. Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol. 2005;23:8580-8587.
10. Dunstan C, Felsenberg D, Seibel MJ. Therapy insight: the risk and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol. 2007;4:42-55.
11. Israel O, Jerushalmi J, Frenkel A, et al. Normal and abnormal single photon emission computed tomography of the skull: comparison with planar scintigraphy. J Nucl Med. 1988;29:1341-1346.
12. Schillaci O, Danieli R, Manni C, Simonetti G. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun. 2004;25:705-710.
13. Horger M, Eschmann SM, Pfannenberg C, et al. Evaluation of combined transmission and emission tomography for classification of skeletal lesions. AJR. 2004;183:655-661.
14. Romer W, Nomayr A, Uder M, Bautz W, Kuwert T. SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients. J Nucl Med. 2006;47:1102-1106.
15. Utsunomiya D, Shiraishi S, Imuta M, et al. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology. 2006;238:264-271.
16. Even-Sapir E. SPECT/multislice low-dose CT: a clinically relevant constituent in the imaging algorithm of nononcologic patients referred for bone scintigraphy. J Nucl Med. 2007;48:319-324.
17. Tow DE, Garcia DA, Jansons D, Sullivan TM, Niederman R. Bone scan in dental diseases. J Nucl Med. 1978;19:845-847.
18. Ahuja RB, Scoutar DS, Moule B, Bessent RG, Gray H. Comparative study of technetium-99m bone scans and orthopantomography in determining mandible invasion in intraoral squamous cell carcinoma. Head Neck. 1990;12:237-243.